Vlad Coric - 03 Feb 2026 Form 4 Insider Report for Veradermics, Inc (MANE)

Role
Director
Signature
/s/ Michael Greco, Attorney-in-Fact
Issuer symbol
MANE
Transactions as of
03 Feb 2026
Net transactions value
+$1,999,982
Form type
4
Filing time
05 Feb 2026, 19:04:25 UTC
Previous filing
07 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coric Vlad Director C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN /s/ Michael Greco, Attorney-in-Fact 05 Feb 2026 0001704317

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MANE Common Stock Conversion of derivative security +33,706 33,706 05 Feb 2026 See Footnote F1, F2
transaction MANE Common Stock Conversion of derivative security +33,706 33,706 05 Feb 2026 See Footnote F1, F3
transaction MANE Common Stock Conversion of derivative security +148,794 +441% 182,500 05 Feb 2026 See Footnote F2, F4
transaction MANE Common Stock Conversion of derivative security +148,794 +441% 182,500 05 Feb 2026 See Footnote F3, F4
transaction MANE Common Stock Conversion of derivative security +78,075 +43% 260,575 05 Feb 2026 See Footnote F2, F5
transaction MANE Common Stock Conversion of derivative security +78,075 +43% 260,575 05 Feb 2026 See Footnote F3, F5
transaction MANE Common Stock Conversion of derivative security +117,112 +913% 129,939 05 Feb 2026 Direct F5
transaction MANE Common Stock Purchase $999,991 +58,823 +23% $17.00 319,398 05 Feb 2026 See Footnote F2
transaction MANE Common Stock Purchase $999,991 +58,823 +23% $17.00 319,398 05 Feb 2026 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MANE Series A Convertible Preferred Stock Conversion of derivative security -33,706 -100% 0 05 Feb 2026 Common Stock 33,706 See Footnote F1, F2
transaction MANE Series A Convertible Preferred Stock Conversion of derivative security -33,706 -100% 0 05 Feb 2026 Common Stock 33,706 See Footnote F1, F3
transaction MANE Series B Convertible Preferred Stock Conversion of derivative security -148,794 -100% 0 05 Feb 2026 Common Stock 148,794 See Footnote F2, F4
transaction MANE Series B Convertible Preferred Stock Conversion of derivative security -148,794 -100% 0 05 Feb 2026 Common Stock 148,794 See Footnote F3, F4
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -78,075 -100% 0 05 Feb 2026 Common Stock 78,075 See Footnote F2, F5
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -78,075 -100% 0 05 Feb 2026 Common Stock 78,075 See Footnote F3, F5
transaction MANE Series C Convertible Preferred Stock Conversion of derivative security -117,112 -100% 0 05 Feb 2026 Common Stock 117,112 Direct F5
transaction MANE Stock Option (Right to Buy) Award $0 +51,525 $0.000000 51,525 03 Feb 2026 Common Stock 51,525 $17.00 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F2 Shares held by Vladimir Coric Family Trust 2013.
F3 Shares held by Vladimir Coric Marital Trust 2013.
F4 On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F5 On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.
F6 This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.